In 2013, Wang et al. proposed a direct interaction between AF and protein kinase C-iota (PKCiota), as AF analogs (aurothiomalate and aurothioglucose) inhibit this enzyme by binding critical cysteine residues [153,154]. Here, PRKCI is linked to atrial fibrillation.